Black Diamond Therapeutics, Inc. (BDTX) vs Promis Neurosciences (PMN)

Black Diamond Therapeutics, Inc. and Promis Neurosciences are both Biotechnology companies. Black Diamond Therapeutics, Inc. and Promis Neurosciences are of similar size ($108.6M and $103.8M). Across the 8 metrics below, Black Diamond Therapeutics, Inc. leads on 7 and Promis Neurosciences on 1.

Valuation

Metric BDTX PMN Biotechnology median
P/E n/m n/m 7.88
P/S n/m 46,834.02 11.47
P/B 1.13 2.09 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.04 n/m 0.74
EV/Sales n/m 24,347.61 10.73
Earnings yield (39.68%) (112.60%) (28.84%)
Free cash flow yield (30.26%) (40.87%) (23.03%)

Profitability

Metric BDTX PMN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (37.21%) (172.30%) (57.72%)
Return on assets (29.21%) (127.57%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDTX PMN Biotechnology median
Revenue growth (TTM) — 450.00% 5.64%
EPS growth (last fiscal year) 130.71% (922.18%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDTX PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.28 7.85 4.73
Net debt to EBITDA (10.01) 0.15 0.96

Dividend

Metric BDTX PMN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BDTX PMN Biotechnology median
Market cap 108.59m 103.76m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack